Inhaltsverzeichnis
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. - Myocardial Perfusion. - Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. - Local and neurohumoral control of coronary blood flow. - ACE-inhibitors in coronary artery disease? . - Myocardial Hypertrophy. - Molecular mechanisms of cardiac gene expression. - Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy. - ACE-inhibitors and coronary microcirculation. - Ventricular Remodelling. - Myocardial fibrosis: role of angiotensin II and aldosterone. - Ventricular remodeling after myocardial infarction. Experimental and clinical studies. - Infarct Size, Reperfusion, Restenosis. - Cardioprotection by ACE-inhibitors in acute myocardial ischemia and infarction? . - Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview. - Angiotensin-converting enzyme inhibitor in a human model of restenosis. - Heart failure. - Pathophysiology of heart failure and the renin-angiotensin-system. - Angiotensin-converting enzyme inhibitors in the treatment of clinical heart failure. - Summary and Perspectives. - A. Basic aspects. - B. Clinical aspects.